In an investigation of tPA expression in primate brain, capillary tPA expression was largely absent; capillaries comprised nearly 40% of all microvessels, yet more than 95% of capillaries showed no immunoreactivity for tPA [26]. and occludin mRNA levels were inversely associated (r=0.68, p<0.05). Conclusions: In thisin vitromodel, barrier properties were strongly linked (by inverse association) with tPA expression of brain microvascular endothelial cells. Key Words:Endothelium, Tissue plasminogen activator, Stroke, Microvasculature, Fibrinolysis == Introduction == Tissue plasminogen activator (tPA), a serine protease regulator of fibrinolysis, is largely endothelial-derived and processes plasminogen into proteolytically active plasmin [1]. Reduced fibrinolytic capacity increases risk of thrombosis, and tPA as pharmacotherapy remains the only proven treatment of acute ischemic stroke [2]. Prior cell culture investigation using brain microvascular endothelial cells and astrocytes has shown that endothelial tPA expression is negatively regulated by astrocytes [3,4]. Astrocyte regulation of tPA was inversely related to barrier properties of brain microvascular endothelial cells [3, 4] and was mediated by TGF-beta [5]. In the current study, we further investigated the relationship between barrier properties of brain microvascular endothelial cells and expression of tPA. Prior CBL0137 work has demonstrated importance of organ-specific regulation of thrombosis and hemostasis [6]. We wished to analyze tPA expression using a monoculture system, thereby avoiding potential confounding effects of a cellular milieu involving multiple cell types. We hypothesized that mind microvascular tPA manifestation and barrier properties of endothelial cells are considerably related. We tested this hypothesis using human brain microvascular endothelial cells (HBECs) and two cAMP providers (forskolin and rolipram) known to enhance barrier characteristicsin vitro[7,8]. == Materials and Methods == == Cell Tradition == HBECs (Applied Cell Biology Study Institute, Kirkland, WA) were cultured in Medium 131 (Cascade Biologics, CBL0137 Portland, OR) comprising microvascular growth product and 5% fetal bovine serum and characterized by immunoreactivity for von Willebrand element (Dako, Carpinteria, CA) and uptake of acetylated LDL labeled with 1-1'-dioctacecyl-1-1-3-3-3'-3'-tetamethyl-indocarbocyanine perchlorate (Biomedical Systems, Stoughton, MA). HBEC passages 5-10 were utilized for experiments. HBECs were plated at denseness of 1105cells/cm2. == Measurement of Trans-Endothelial CBL0137 Electrical Resistance Rabbit Polyclonal to RASA3 == We measured trans-endothelial electrical resistance (TEER) using two different CBL0137 systems. With the CBL0137 first system (ECIS method), continuous changes in TEER were monitored in real-time by electric cell-substrate impedance sensing (ECIS) using ECIS Model 1600R instrument (Applied BioPhysics, Troy, NY), as previously described [8]. HBECs were plated into 8-well arrays (8W10E), each well comprising ten platinum microelectrodes, 72 hours prior to addition of 50 uM forskolin (Sigma, St Louis, MO) and/or 10 uM rolipram (A.G. Scientific, San Diego, CA). Long-term resistance changes were monitored at 400 Hz. Data were instantly and continually collected and recorded by computer. Experiments were performed after cells reached confluence, with basal TEER ideals > 1500 . Resistance was determined by subtracting resistance readings of cell-free preparations from that of HBEC preparations and are demonstrated as percentage switch, as previously described [9-19]. Conditioned press were collected and freezing at -80 C prior to enzyme immunoassay. On day time six, cells were harvested and utilized for quantitative PCR analysis. In separate experiments carried out as above, we added 250 ng/ml tPA (American Diagnostica Inc., Stamford, CT) to cell tradition preparations at the same time mainly because the addition of forskolin and/or rolipram. The second method (transwell system) measured TEER using a EVOM Voltohmmeter (World Precision Instrument, Sarasota, FL). HBECs were plated into 12-well transwells at 105cells/cm272 hours prior to addition of 50 uM forskolin and 10 uM rolipram..
